GreenLight Biosciences Holdings

GRNA · NASDAQ
Analyze with AI
3/31/2023
12/31/2022
9/30/2022
6/30/2022
Operating Activities
Net Income-$28-$39-$38-$52
Dep. & Amort.$2$2$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$2$3$2
Change in WC-$8$5-$7$27
Other Non-Cash$1$5$1-$1
Operating Cash Flow-$31-$25-$40-$23
Investing Activities
PP&E Inv.-$2-$4-$10-$13
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$2-$4-$10-$13
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0-$0$106$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$3-$2$104-$4
Financing Cash Flow-$3-$2$104-$4
Forex Effect$0$0$0$0
Net Chg. in Cash-$36-$30$54-$39
Supplemental Information
Beg. Cash$69$100$45$85
End Cash$34$69$100$45
Free Cash Flow-$33-$28-$50-$35
GreenLight Biosciences Holdings (GRNA) Financial Statements & Key Stats | AlphaPilot